Back
I-MAB 10K Form
Sell
39
IMAB
I-MAB
Last Price:
1.81
Seasonality Move:
32.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMAB News And Ratings
See the #1 stock for the next 7 days that we like better than IMAB
IMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $-32.99M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.08 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.80570 |
|---|---|
| Net Income (TTM): | $-315.57M |
| Gross Margin: | $-37.04M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
I-MAB Earnings Forecast
Key I-MAB Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 2 years.
I-MAB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMAB |
| Website: | i-mabbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |